Psychiatry and Mental Health - Global Neurology Academy

33-48 of 86

From Trials to Practice: Evaluating Xanomeline-Trospium Chloride for Schizophrenia
From Trials to Practice: Evaluating Xanomeline-Trospium Chloride for Schizophrenia
NeuroFrontiers
From Trials to Practice: Evaluating Xanomeline-Trospium Chloride for Schizophrenia
- Ashley Baker, MSN, PMHNP
- Steven Paul, MD
Social Support in Schizophrenia: The Role of Emotional Awareness and Regulation
Social Support in Schizophrenia: The Role of Emotional Awareness and Regulation
NeuroFrontiers
Social Support in Schizophrenia: The Role of Emotional Awareness and Regulation
- David Kimhy, PhD
Genetics and Schizophrenia: Key Ethical Considerations
Genetics and Schizophrenia: Key Ethical Considerations
NeuroFrontiers
Genetics and Schizophrenia: Key Ethical Considerations
- Aaron Besterman, MD
Understanding Schizophrenia: New Insights on Prevalence, Treatment, and Quality of Life
Understanding Schizophrenia: New Insights on Prevalence, Treatment, and Quality of Life
NeuroFrontiers
Understanding Schizophrenia: New Insights on Prevalence, Treatment, and Quality of Life
- Natalie Bareis, PhD, LMSW
Gaps in Schizophrenia Spectrum Disorders Care: A Look at Causes and Solutions
Gaps in Schizophrenia Spectrum Disorders Care: A Look at Causes and Solutions
NeuroFrontiers
Gaps in Schizophrenia Spectrum Disorders Care: A Look at Causes and Solutions
- Natalie Bareis, PhD, LMSW
Schizophrenia Care: Managing Symptoms with Muscarinic Receptor Agonists
Schizophrenia Care: Managing Symptoms with Muscarinic Receptor Agonists
On the Frontlines of Schizophrenia
Schizophrenia Care: Managing Symptoms with Muscarinic Receptor Agonists
- Steven Paul, MD
Developments in Schizophrenia Care: An Alternative to Dopamine Receptor Blockage
Developments in Schizophrenia Care: An Alternative to Dopamine Receptor Blockage
NeuroFrontiers
Developments in Schizophrenia Care: An Alternative to Dopamine Receptor Blockage
- Steven Paul, MD
Schizophrenia Care: Improving Social Cognition and Motivation
Schizophrenia Care: Improving Social Cognition and Motivation
On the Frontlines of Schizophrenia
Schizophrenia Care: Improving Social Cognition and Motivation
- Michael Green, PhD
Examining Schizophrenia Risk: The Influence of B12 Levels in Early Pregnancy
Examining Schizophrenia Risk: The Influence of B12 Levels in Early Pregnancy
NeuroFrontiers
Examining Schizophrenia Risk: The Influence of B12 Levels in Early Pregnancy
Unseen Struggles: Impacts of Homelessness on Women with Schizophrenia
Unseen Struggles: Impacts of Homelessness on Women with Schizophrenia
NeuroFrontiers
Unseen Struggles: Impacts of Homelessness on Women with Schizophrenia
Transforming Schizophrenia Treatment: Advances in Medication and Therapy
Transforming Schizophrenia Treatment: Advances in Medication and Therapy
NeuroFrontiers
Transforming Schizophrenia Treatment: Advances in Medication and Therapy
- Robert Walker, PharmD
- Deanna L. Kelly, PharmD, BCPP
Advancing Schizophrenia Care: Challenges and Promising New Therapies
Advancing Schizophrenia Care: Challenges and Promising New Therapies
NeuroFrontiers
Advancing Schizophrenia Care: Challenges and Promising New Therapies
- Charles Turck, PharmD, BCPS, BCCCP
- Andrew J. Cutler, MD
Schizophrenia and Heart Health: Navigating the Hidden Risk of Sudden Cardiac Death
Schizophrenia and Heart Health: Navigating the Hidden Risk of Sudden Cardiac Death
NeuroFrontiers
Schizophrenia and Heart Health: Navigating the Hidden Risk of Sudden Cardiac Death
The Silent Struggle: Understanding ADHD's Impact on Girls and Women
The Silent Struggle: Understanding ADHD's Impact on Girls and Women
NeuroFrontiers
The Silent Struggle: Understanding ADHD's Impact on Girls and Women
- Kathleen Nadeau, PhD
Addressing ADHD in Women: A Guide to Diagnosis and Treatment
Addressing ADHD in Women: A Guide to Diagnosis and Treatment
NeuroFrontiers
Addressing ADHD in Women: A Guide to Diagnosis and Treatment
- Ashley Baker, MSN, PMHNP
- Kathleen Nadeau, PhD
Understanding the Cardiovascular Risks of ADHD Medications
Understanding the Cardiovascular Risks of ADHD Medications
NeuroFrontiers
Understanding the Cardiovascular Risks of ADHD Medications

3/6